Adaptive trial designs offer oncology studies the flexibility and efficiency crucial for multi-regional clinical trials (MRCTs). Discover the complexities and advantages of these designs, from diverse regulatory landscapes to cultural nuances, in our blog: https://ow.ly/bVhf50SURWy
Worldwide Clinical Trials
Research Services
Research Triangle Park, NC 165,725 followers
As a leading full-service global CRO, we work to create solutions that advance new treatments from discovery to reality.
About us
About Worldwide Clinical Trials Worldwide Clinical Trials is a leading full-service global contract research organization (CRO) that works in partnership with biotechnology and pharmaceutical companies to create customized solutions that advance new treatments. Our capabilities include bioanalytical laboratory services, Phase I-IV clinical trials, and post-approval and real-world evidence studies – all powered by our team members who bring their expertise and a collaborative, personalized approach to each clinical program. Anchored in our company’s scientific heritage, our dedicated therapeutic focus on cardiovascular, metabolic, neuroscience, oncology, and rare diseases, is applied to develop flexible plans and solve problems quickly for our customers. Our talented team of 3,000+ professionals spans 60+ countries, and embraces a culture of diversity, equity, inclusion, and belonging (DEI&B). We are united in cause with our customers to improve the lives of patients through new, innovative therapies. For more information on Worldwide, visit www.Worldwide.com.
- Website
-
http://www.worldwide.com
External link for Worldwide Clinical Trials
- Industry
- Research Services
- Company size
- 1,001-5,000 employees
- Headquarters
- Research Triangle Park, NC
- Type
- Privately Held
- Specialties
- Neuroscience/Central Nervous System Clinical Research, Rare Disease Clinical Research, Oncology - Solid Tumors Clinical Research, General Medicine Clinical Research, Cardiovascular and Metabolic Clinical Research, Rare Disease, Early Phase , and Clinical Trials
Locations
Employees at Worldwide Clinical Trials
Updates
-
What fantastic news for the rare disease research community today! Hear from our Therapeutic Strategy Lead, Rare Disease, Juliane Mills: "We are grateful to the FDA for listening to the needs and concerns of the Niemann-Pick Type C community and reviewing data for this new therapy through that lens. Having treatment options available for a disease helps drive diagnosis of that disease. We're hopeful this will help to shorten the time to diagnosis for patients living with NPC and reduce the impact on quality of life through earlier treatment." https://ow.ly/2Pz750ST8cs
FDA committee endorses Zevra Therapeutics' arimoclomol as a treatment
https://business-news-today.com
-
What strategic approaches and innovative solutions are necessary for your complex and adaptive oncology clinical trial design? Find out from our oncology experts, Matt Cooper and james eamma, in our upcoming webinar. Register today to watch on August 21, 2024, at 10 am EDT: https://ow.ly/rI4O50SSh6k To meet Matt and James in person, make sure to stop by Booth 411 during #ESMO24: https://ow.ly/z20N50SSh8N
Navigating Complex & Adaptive Oncology Trials: Key Challenges & Solutions
brighttalk.com
-
We're happy to be working with BSI Life Sciences and Zelta by Merative to help streamline our drug development efforts around the globe. Looking forward to continued collaboration!
BSI Life Sciences and Zelta by Merative announce the adoption of BSI's Clinical Trial Management System (BSI #CTMS) by leading global #CRO, Worldwide Clinical Trials. Learn more in our #PressRelease. https://lnkd.in/ejh4KEf4 #eClinical #LifeSciences #ClinicalTrials
Today’s Latest Company Press Release Worldwide CRO
bsi-lifesciences.com
-
WorldwideEdge reflects our dedication to innovation and continuous improvement. We understand the complexities of clinical trials and the importance of efficient, high-quality service. Join us in enhancing your drug development journey with our commitment to operational excellence and superior customer experience. Learn more: https://ow.ly/3ik350SPu6B
-
Join our experienced team at #ESMO24 this year because when difficulties arise in your oncology drug development program, you need a CRO that’s experienced in managing these obstacles. Although oncology research isn’t a straight line, our team is here to help every step of the way. Come and say hello at Booth 411 in Barcelona next month! https://ow.ly/NP5K50SQg9t
-
In immunotherapy, immune-related adverse events (irAREs) may be a possibility. That’s why you need a CRO with innovative clinical trial services intentionally designed to capture and assess these late-onset toxicities or delayed efficacy responses. Learn more about our trial design and methodological considerations in our white paper: https://ow.ly/xqjO50SOxhU Stop by Booth 411 at ESMO to discuss your immunotherapy clinical trial with our experienced oncology team: https://ow.ly/wAvf50SOxkp
Immuno-Oncology: Managing Tomorrow’s Responses Today
worldwide.com
-
How do you minimize radiation exposure and ensure radiopharmaceuticals are suitable for your patient population? Find out the answers and more on the latest in radiopharmaceuticals research in Anna Chwalba’s and Sue Batchelor’s blog: https://ow.ly/25zP50SMi3V
Patient Safety and Radiopharmaceuticals Administration: Minimizing Radiation Exposure and Risks
worldwide.com
-
At Worldwide, partnerships are at the core of everything we do. Check out these insights from the 13th Annual Clinical Trials in Oncology East Coast 2024 conference, where experts underscored the pivotal role of strong relationships in advancing drug development. In this article, james eamma, our Executive Director, Therapeutic Strategy Lead, Oncology, discusses the transformative impact of FDA’s Project Optimus in redefining dose optimization for oncology programs. Check it out today: https://ow.ly/8WaF50SMIls
Partner relationships drive optimised oncology clinical trials
clinicaltrialsarena.com